Search

Indication: BarifTM is indicated for the chronic management of hyperuricemia in patients with gout. BarifTM is not recommended for the treatment of asymptomatic hyperuricemia.Dosage & Administration:BarifTM is recommended at 40 mg or 80 mg once daily. The recommended starting dos..

Generic NameFebuxostat Strength40 mg Dosage FormTablet ManufacturerSquare Pharmaceuticals PLC Therapeutic ClassDrugs used in Gout Pack Size3 x 10's Tablet (Strip)Overview Barif 40 mg Tablet is manufactured by Square Pharmaceuticals PLC, containing Febuxostat as its active ingredient. F..

Generic NameFebuxostat Strength40 mg Dosage FormTablet ManufacturerSquare Pharmaceuticals PLC Therapeutic ClassDrugs used in Gout Pack Size3 x 10's Tablet (Strip)Overview Barif 40 mg Tablet is manufactured by Square Pharmaceuticals PLC, containing Febuxostat as its active ingredient. F..